Income Statement Kajima Corporation

Equities

1812

JP3210200006

Construction & Engineering

Delayed Japan Exchange Other stock markets 02:00:00 2024-09-18 am EDT			5-day change	1st Jan Change
2,641.00 ^JPY	+1.75%		+2.17%	+12.07%

Aug. 06	Kajima Corporation Provides Consolidated and Non-Consolidated Earnings Guidance for the Year Ending March 31, 2025	CI
Aug. 06	Kajima Corporation Provides Dividend Guidance for the Second Quarter End of Fiscal Year Ending March 31, 2025	CI

3c55085fb8a1e5.LeFvgt4KQ4oeE6WSCXtGubzt5zyqVSy0sDaJK1yYG3Q.ZJkO6qduGsRbecTAfgIg69-n3lTyM2r_0VrzRTLHSx5Crg7lkT0I6XBy9A

Published financial data: KAJIMA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	2,011B	1,907B	2,080B	2,392B	2,665B
Other Revenues, Total	-	-	-	1M	-
Total Revenues	2,011B	1,907B	2,080B	2,392B	2,665B
Cost of Goods Sold, Total	1,763B	1,666B	1,824B	2,124B	2,374B
Gross Profit	248B	241B	256B	267B	292B
Selling General & Admin Expenses, Total	100B	99.89B	116B	125B	137B
Provision for Bad Debts	332M	306M	1.01B	3.26B	1.27B
R&D Expenses	15.78B	14.13B	15.75B	16.06B	17.58B
Other Operating Expenses, Total	116B	114B	132B	144B	156B
Operating Income	132B	127B	123B	123B	136B
Interest Expense, Total	-3.5B	-2.66B	-2.36B	-4.81B	-14.4B
Interest And Investment Income	11.43B	10.76B	11.88B	16.51B	16.2B
Net Interest Expenses	7.93B	8.1B	9.52B	11.7B	1.8B
Income (Loss) On Equity Invest.	-	3.53B	6.97B	5.62B	4.06B
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	6.73B	1.01B	12.26B	16.18B	8.42B
EBT, Excl. Unusual Items	147B	140B	152B	157B	150B
Gain (Loss) On Sale Of Investments	578M	4.42B	17.47B	7.04B	19.83B
Gain (Loss) On Sale Of Assets	637M	2.37B	244M	4.24B	402M
Asset Writedown	-1.1B	-1.24B	-17.83B	-754M	-1.34B
Legal Settlements	-28M	-33M	-1.61B	-3M	-65M
Other Unusual Items	2.9B	-2M	-1M	-1M	0
EBT, Incl. Unusual Items	150B	145B	150B	167B	169B
Income Tax Expense	45.85B	46.48B	50.22B	53.19B	52.32B
Earnings From Continuing Operations	104B	98.77B	100B	114B	117B
Net Income to Company	104B	98.77B	100B	114B	117B
Minority Interest	-544M	-245M	3.72B	-2.28B	-1.58B
Net Income - (IS)	103B	98.52B	104B	112B	115B
Net Income to Common Incl Extra Items	103B	98.52B	104B	112B	115B
Net Income to Common Excl. Extra Items	103B	98.52B	104B	112B	115B
Per Share Items
Net EPS - Basic	200.99	193.13	208	227.98	238.76
Basic EPS - Continuing Operations	200.99	193.13	208	227.98	238.76
Basic Weighted Average Shares Outstanding	514M	510M	499M	490M	482M
Net EPS - Diluted	200.99	193.13	208	227.98	238.76
Diluted EPS - Continuing Operations	200.99	193.13	208	227.98	238.76
Diluted Weighted Average Shares Outstanding	514M	510M	499M	490M	482M
Normalized Basic EPS	177.37	170.71	197.81	195.13	191.45
Normalized Diluted EPS	177.37	170.71	197.81	195.13	191.45
Dividend Per Share	50	54	58	70	90
Payout Ratio	25.48	26.02	27.08	26.44	32.04
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	152B	146B	146B	148B	163B
EBITA	132B	127B	123B	123B	136B
EBIT	132B	127B	123B	123B	136B
Effective Tax Rate - (Ratio)	30.64	32	33.4	31.8	30.97
Normalized Net Income	91.11B	87.09B	98.78B	95.68B	92.24B
Non-Cash Pension Expense	885M	837M	715M	724M	560M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	16.44B	15.03B	17.36B	18.22B	20.76B

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	263B	308B	273B	286B	355B
Short Term Investments	110M	325M	187M	383M	170M
Total Cash And Short Term Investments	263B	308B	273B	286B	355B
Accounts Receivable, Total	746B	614B	737B	906B	945B
Total Receivables	746B	614B	737B	906B	945B
Inventory	219B	254B	271B	430B	495B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	121B	87.73B	109B	130B	124B
Total Current Assets	1,349B	1,263B	1,391B	1,752B	1,918B
Net Property Plant And Equipment	391B	418B	428B	479B	540B
Long-term Investments	352B	402B	425B	438B	548B
Other Intangibles, Total	11.55B	11.33B	14.9B	27.73B	26.65B
Loans Receivable Long-Term	50.01B	62.95B	69.02B	60.2B	98.76B
Deferred Tax Assets Long-Term	18.64B	8.03B	10.14B	13.35B	3.41B
Other Long-Term Assets, Total	1M	1M	1M	2M	3M
Total Assets	2,172B	2,165B	2,338B	2,770B	3,135B
Liabilities
Accounts Payable, Total	521B	446B	502B	604B	584B
Accrued Expenses, Total	153M	142M	141M	154M	205M
Short-term Borrowings	196B	143B	215B	284B	324B
Current Portion of Long-Term Debt	-	10B	-	38M	35.27B
Current Income Taxes Payable	30.6B	27.62B	22.7B	25.28B	32.61B
Unearned Revenue Current, Total	162B	146B	124B	150B	203B
Other Current Liabilities	215B	217B	244B	256B	326B
Total Current Liabilities	1,125B	990B	1,108B	1,320B	1,506B
Long-Term Debt	130B	164B	145B	253B	253B
Pension & Other Post Retirement Benefits	62.1B	62.58B	63.18B	62.1B	61.34B
Deferred Tax Liability Non Current	20.46B	21.68B	22.35B	20.88B	33.14B
Other Non Current Liabilities	37.69B	42.05B	45.8B	52.47B	57.94B
Total Liabilities	1,376B	1,280B	1,384B	1,709B	1,911B
Common Stock, Total	81.45B	81.45B	81.45B	81.45B	81.45B
Additional Paid In Capital	43.37B	43.27B	42.31B	41.99B	43.82B
Retained Earnings	583B	654B	731B	814B	892B
Treasury Stock	-16.42B	-26.17B	-45.92B	-55.67B	-67.51B
Comprehensive Income and Other	100B	122B	137B	171B	260B
Total Common Equity	792B	875B	946B	1,052B	1,210B
Minority Interest	4.23B	9.97B	7.86B	8.71B	13.52B
Total Equity	796B	885B	954B	1,061B	1,224B
Total Liabilities And Equity	2,172B	2,165B	2,338B	2,770B	3,135B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	513M	505M	492M	481M	481M
ECS Total Common Shares Outstanding	513M	505M	492M	486M	481M
Book Value / Share	1.54K	1.73K	1.92K	2.17K	2.51K
Tangible Book Value	780B	864B	931B	1,025B	1,183B
Tangible Book Value Per Share	1.52K	1.71K	1.89K	2.11K	2.46K
Total Debt	327B	317B	360B	538B	613B
Net Debt	63.81B	9.07B	86.41B	252B	258B
Debt Equivalent of Unfunded Proj. Benefit Obligation	61.46B	61.04B	61.87B	60.58B	56.63B
Minority Interest, Total (Incl. Fin. Div)	4.23B	9.97B	7.86B	8.71B	13.52B
Inventories - Work In Process, Total	138B	158B	193B	278B	269B
Inventories - Finished Goods, Total	62.82B	78.21B	74.04B	145B	222B
Inventories - Others	18.18B	17.09B	4.66B	6.86B	3.76B
Full Time Employees	18.67K	18.9K	19.3K	19.4K	19.81K
Accumulated Allowance for Doubtful Accounts (Supple)	855M	980M	1.96B	5.42B	6.67B

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	150B	145B	150B	167B	169B
Depreciation & Amortization - CF	19.96B	19.08B	22.61B	24.71B	27.27B
Depreciation & Amortization, Total	19.96B	19.08B	22.61B	24.71B	27.27B
(Gain) Loss From Sale Of Asset	449M	-1.13B	17.59B	-3.48B	942M
(Gain) Loss on Sale of Investments - (CF)	557M	-4.42B	-17.47B	-7.04B	-13.65B
(Income) Loss On Equity Investments - (CF)	-	-3.53B	-6.97B	-5.62B	-4.06B
Other Operating Activities, Total	-43.56B	-45.38B	-51.47B	-56.17B	-51.86B
Change In Accounts Receivable	-33.3B	129B	-68.76B	-158B	-31.64B
Change In Inventories	-31.04B	-41.11B	-62.84B	-141B	-48.71B
Change In Accounts Payable	-8.69B	-72.15B	61.56B	87.94B	-33.2B
Change in Other Net Operating Assets	-944M	27.81B	-14.41B	61.53B	110B
Cash from Operations	53.06B	153B	30.22B	-29.12B	124B
Capital Expenditure	-81.16B	-46.36B	-49.41B	-60.74B	-41.5B
Sale of Property, Plant, and Equipment	5.52B	4.22B	4B	11.82B	1.26B
Cash Acquisitions	-376M	-	-2.69B	-	-2.45B
Sale (Purchase) of Intangible assets	-2.7B	-2.98B	-3.67B	-14.51B	-2.64B
Investment in Marketable and Equity Securities, Total	-13.8B	-2.2B	10.72B	6.03B	10.23B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-12.54B	-9.48B	548M	-16.17B	-15.54B
Other Investing Activities, Total	3.24B	-8.63B	-10.67B	-8.18B	-12.28B
Cash from Investing	-102B	-65.43B	-51.17B	-81.74B	-62.92B
Short Term Debt Issued, Total	24.95B	35.09B	48.06B	59.68B	36.08B
Long-Term Debt Issued, Total	34.76B	62.96B	78.14B	144B	107B
Total Debt Issued	59.71B	98.05B	126B	204B	143B
Short Term Debt Repaid, Total	-	-45B	-	-	-40B
Long-Term Debt Repaid, Total	-30.83B	-60.16B	-95.76B	-46.4B	-64.75B
Total Debt Repaid	-30.83B	-105B	-95.76B	-46.4B	-105B
Issuance of Common Stock	-	-	-	-	5.04B
Repurchase of Common Stock	-10.01B	-10.01B	-20.01B	-10.02B	-15.06B
Common & Preferred Stock Dividends Paid	-26.31B	-25.63B	-28.12B	-29.55B	-36.85B
Common & Preferred Stock Dividends Paid	-26.31B	-25.63B	-28.12B	-29.55B	-36.85B
Other Financing Activities, Total	-3.43B	3.64B	-3.24B	-6.01B	-805M
Cash from Financing	-10.87B	-39.11B	-20.93B	112B	-9.57B
Foreign Exchange Rate Adjustments	-186M	-3.21B	8.62B	13.49B	9.63B
Miscellaneous Cash Flow Adjustments	-1M	-1M	1M	-	6.94B
Net Change in Cash	-59.8B	45.34B	-33.26B	14.52B	67.81B
Supplemental Items
Cash Interest Paid	3.45B	2.7B	2.22B	4.15B	13.45B
Cash Income Tax Paid (Refund)	36.69B	50.3B	54.07B	54.3B	50.54B
Levered Free Cash Flow	-63.92B	86.42B	-60.81B	-182B	72.41B
Unlevered Free Cash Flow	-61.74B	88.08B	-59.34B	-179B	81.41B
Change In Net Working Capital	80.33B	-38.92B	106B	206B	-13.39B
Net Debt Issued / Repaid	28.88B	-7.11B	30.45B	157B	38.1B

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.87	3.66	3.42	3.02	2.88
Return on Total Capital	7.57	6.83	6.13	5.29	4.94
Return On Equity %	13.37	11.75	10.9	11.32	10.21
Return on Common Equity	13.36	11.82	11.41	11.19	10.17
Margin Analysis
Gross Profit Margin %	12.34	12.66	12.3	11.17	10.94
SG&A Margin	4.97	5.24	5.56	5.21	5.13
EBITDA Margin %	7.56	7.66	7.02	6.19	6.12
EBITA Margin %	6.56	6.66	5.93	5.15	5.1
EBIT Margin %	6.56	6.66	5.93	5.15	5.1
Income From Continuing Operations Margin %	5.16	5.18	4.82	4.77	4.38
Net Income Margin %	5.13	5.17	4.99	4.67	4.32
Net Avail. For Common Margin %	5.13	5.17	4.99	4.67	4.32
Normalized Net Income Margin	4.53	4.57	4.75	4	3.46
Levered Free Cash Flow Margin	-3.18	4.53	-2.92	-7.62	2.72
Unlevered Free Cash Flow Margin	-3.07	4.62	-2.85	-7.5	3.05
Asset Turnover
Asset Turnover	0.94	0.88	0.92	0.94	0.9
Fixed Assets Turnover	5.56	4.71	4.92	5.28	5.23
Receivables Turnover (Average Receivables)	2.76	2.81	3.08	2.91	2.88
Inventory Turnover (Average Inventory)	8.64	7.04	6.95	6.06	5.14
Short Term Liquidity
Current Ratio	1.2	1.28	1.26	1.33	1.27
Quick Ratio	0.9	0.93	0.91	0.9	0.86
Operating Cash Flow to Current Liabilities	0.05	0.15	0.03	-0.02	0.08
Days Sales Outstanding (Average Receivables)	132.8	130.06	118.47	125.33	127.08
Days Outstanding Inventory (Average Inventory)	42.35	51.82	52.53	60.21	71.25
Average Days Payable Outstanding	107.26	103.71	93.91	88.4	89.14
Cash Conversion Cycle (Average Days)	67.88	78.17	77.09	97.13	109.19
Long Term Solvency
Total Debt/Equity	41.06	35.83	37.74	50.68	50.07
Total Debt / Total Capital	29.11	26.38	27.4	33.63	33.36
LT Debt/Equity	16.38	18.49	15.22	23.88	20.68
Long-Term Debt / Total Capital	11.61	13.61	11.05	15.85	13.78
Total Liabilities / Total Assets	63.35	59.13	59.21	61.69	60.97
EBIT / Interest Expense	37.69	47.83	52.23	25.62	9.43
EBITDA / Interest Expense	43.39	55.01	61.8	30.76	11.33
(EBITDA - Capex) / Interest Expense	20.21	37.56	40.88	18.13	8.44
Total Debt / EBITDA	2.15	2.17	2.47	3.64	3.76
Net Debt / EBITDA	0.42	0.06	0.59	1.7	1.58
Total Debt / (EBITDA - Capex)	4.62	3.18	3.73	6.17